It's called myasthenia gravis and affects only about 37 out of every 100,000 people in the United States. Despite being so rare, "improved awareness and diagnostic techniques have led to more ...

While myasthenia gravis is a chronic condition that doesn ... and is approved for people who have tested positive for anti-acetylcholine receptor antibodies. Taking eculizumab may increase ...

That's the literal definition or literal meaning of the term myasthenia gravis. So people with myasthenia gravis present obviously with muscle weakness, but the characteristic of this muscle ...

My blog Ashley's Anatomy pretty much goes in depth about myasthenia gravis. I had a lot of free time, hospital, bed-ridden. So I spent a lot of time sharing my experience educating people ...

In part 2 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the challenge inherent ...

The Neuromuscular Disease Center has a long history of providing excellent clinical care and research in myasthenia gravis. Myasthenia gravis is a chronic autoimmune disorder that causes muscle ...

Patients with generalized myasthenia gravis experienced durable improvements ... in the ADAPT studies,” they wrote. About 85% of people with gMG are positive for AChR autoantibodies.

This SPA agreement marks an important milestone in the development of Descartes-08 for MG, providing critical regulatory clarity and a clear path toward potential approval,” said Carsten Brunn, Ph.D., ...

The FDA has granted Priority Review to nipocalimab for the treatment of antibody positive patients with generalized myasthenia gravis.

USA-based healthcare giant Johnson & Johnson has announced the publication of key Phase III data for nipocalimab in The ...